Case Updates
SICC upholds USD730m worldwide freezing order obtained by Novo Nordisk and confirms grant of first reported instance of an anti-anti-suit-injunction restraining Danish proceedings
The Singapore International Commercial Court has upheld a USD730m worldwide freezing injunction in Novo Nordisk A/S v KBP Biosciences Pte Ltd and others [2025] SGHC(I) 22 in support of a ICC claim brought by Danish pharmaceutical group Novo Nordisk over a failed hypertension drug. The Setia Law team comprising Danny Ong, Jason Teo, Lee Jin Loong and Elvis Zhang, acted for the claimant in both the original ex parte application and the successful defence against the set-aside.
12 August 2025